Management of Pediatric Status Epilepticus

Pediatric Neurology (HS Singer, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Pediatric Neurology

Opinion statement

Status epilepticus (SE) is a medical emergency consisting of persistent or recurring seizures without a return to baseline mental status. SE can be divided into subtypes based on seizure types and underlying etiologies. Management should be implemented rapidly and based on pre-determined care pathways. The aim is to terminate seizures while simultaneously identifying and managing precipitant conditions. Seizure management involves “emergent” treatment with benzodiazepines (lorazepam intravenously, midazolam intramuscularly, or diazepam rectally) followed by “urgent” therapy (phenytoin/fosphenytoin, phenobarbital, levetiracetam or valproate sodium). If seizures persist, “refractory” treatments include infusions of midazolam or pentobarbital. Prognosis is dependent on the underlying etiology and seizure persistence. This article reviews the current management strategies for pediatric convulsive SE.

Keywords

Status epilepticus SE Seizure Pediatric Management 

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.••
    Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23. This guideline discusses the management of status epilepticus in children, including anoverall approach, acute medical management, and anti-seizure medications.PubMedCrossRefGoogle Scholar
  2. 2.
    Riviello JJ, Ashwal S, Hirtz D, et al. Practice Parameter: diagnostic assessment of the child with status epilepticus (an evidence-based review). Neurology. 2006;67:1542–50.PubMedCrossRefGoogle Scholar
  3. 3.
    Singh RK, Stephens S, Berl MM, et al. Prospective study of new-onset seizures presenting as status epilepticus in childhood. Neurology. 2010;74(8):636–42.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Chin RF, Neville BG, Peckham C, et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006;368(9531):222–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Berg AT, Shinnar S, Levy SR, et al. Status epilepticus in children with newly diagnosed epilepsy. Ann Neurol. 1999;45(5):618–23.PubMedCrossRefGoogle Scholar
  6. 6.
    Eriksson K, Metsaranta P, Huhtala H, et al. Treatment delay and the risk of prolonged status epilepticus. Neurology. 2005;65(8):1316–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Lewena S, Young S. When benzodiazepines fail: how effective is second line therapy for status epilepticus in children? Emerg Med Australas. 2006;18(1):45–50.PubMedCrossRefGoogle Scholar
  8. 8.
    Hayashi K, Osawa M, Aihara M, et al. Efficacy of intravenous midazolam for status epilepticus in childhood. Pediatr Neurol. 2007;36(6):366–72.PubMedCrossRefGoogle Scholar
  9. 9.
    Jacob TC, Moss SJ, Jurd R. GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat Rev Neurosci. 2008;9(5):331–43.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Goodkin HP, Joshi S, Mtchedlishvili Z, et al. Subunit-specific trafficking of GABA(A) receptors during status epilepticus. J Neurosci. 2008;28(10):2527–38.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Pakalnis A, Paolicchi J, Gilles E. Psychogenic status epilepticus in children: psychiatric and other risk factors. Neurology. 2000;54(4):969–70.PubMedCrossRefGoogle Scholar
  12. 12.
    Papavasiliou A, Vassilaki N, Paraskevoulakos E, et al. Psychogenic status epilepticus in children. Epilepsy Behav. 2004;5(4):539–46.PubMedCrossRefGoogle Scholar
  13. 13.
    Kirkham FJ, Wade AM, McElduff F, et al. Seizures in 204 comatose children: incidence and outcome. Intensive Care Med. 2012;38(5):853–62.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Topjian AA, Gutierrez-Colina AM, Sanchez SM, et al. Electrographic status epilepticus is associated with mortality and worse short-term outcome in critically ill children. Crit Care Med. 2013;31:215–23.Google Scholar
  15. 15.
    Abend NS, Arndt DH, Carpenter JL, et al. Electrographic seizures in pediatric ICU patients: Cohort study of risk factors and mortality. Neurology. 2013;81(4):383–91.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Wagenman KL, Blake TP, Sanchez SM, et al. Electrographic status epilepticus and long-term outcome in critically ill children. Neurology. 2014;82(5):396–404.PubMedCrossRefGoogle Scholar
  17. 17.
    Payne ET, Zhao XY, Frndova H, et al. Seizure burden is independently associated with short term outcome in critically ill children. Brain. 2014;137:1429–38.PubMedCrossRefGoogle Scholar
  18. 18.
    Abend NS, Gutierrez-Colina AM, Topjian AA, et al. Nonconvulsive seizures are common in critically ill children. Neurology. 2011;76(12):1071–7.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Williams K, Jarrar R, Buchhalter J. Continuous video-EEG monitoring in pediatric intensive care units. Epilepsia. 2011;52(6):1130–6.PubMedCrossRefGoogle Scholar
  20. 20.•
    Sanchez Fernandez I, Abend NS, Arndt DH, et al. Electrographic seizures after convulsive status epilepticus in children and young adults. A retrospective multicenter study. J Pediatr. 2014;164(2):339–46. This multicenter observational study addresses the use of EEG monitoring in children presenting with convulsive status epilepticus.PubMedCrossRefGoogle Scholar
  21. 21.•
    Cook AM, Castle A, Green A, et al. Practice variations in the management of status epilepticus. Neurocrit Care. 2012;17(1):24–30. This study summarizes current practice related to status epilepticus management, including variation across institutions.PubMedCrossRefGoogle Scholar
  22. 22.
    Shorvon S, Baulac M, Cross H, et al. The drug treatment of status epilepticus in Europe: Consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia. 2008;49(7):1277–86.PubMedGoogle Scholar
  23. 23.
    Tobias JD, Berkenbosch JW. Management of status epilepticus in infants and children prior to pediatric ICU admission: deviations from the current guidelines. South Med J. 2008;101(3):268–72.PubMedCrossRefGoogle Scholar
  24. 24.
    Lewena S, Pennington V, Acworth J, et al. Emergency management of pediatric convulsive status epilepticus: a multicenter study of 542 patients. Pediatr Emerg Care. 2009;25(2):83–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Chin RF, Verhulst L, Neville BG, et al. Inappropriate emergency management of status epilepticus in children contributes to need for intensive care. J Neurol Neurosurg Psychiatry. 2004;75(11):1584–8.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Tirupathi S, McMenamin JB, Webb DW. Analysis of factors influencing admission to intensive care following convulsive status epilepticus in children. Seizure. 2009;18(9):630–3.PubMedCrossRefGoogle Scholar
  27. 27.
    Sreenath TG, Gupta P, Sharma KK, et al. Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: A randomized controlled trial. Eur J Paediatr Neurol. 2010;14(2):162–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Appleton R, Macleod S, Martland T. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev. 2008;3:CD001905.PubMedGoogle Scholar
  29. 29.
    McMullan J, Sasson C, Pancioli A, et al. Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis. Acad Emerg Med. 2010;17(6):575–82.PubMedCrossRefGoogle Scholar
  30. 30.
    Shaner DM, McCurdy SA, Herring MO, et al. Treatment of status epileticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology. 1988;38:202–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Crawford TO, Mitchell WG, Fishman LS, et al. Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology. 1988;38(7):1035–40.PubMedCrossRefGoogle Scholar
  32. 32.
    Wilmshurst JM, van der Walt JS, Ackermann S, et al. Rescue therapy with high-dose oral phenobarbitone loading for refractory status epilepticus. J Paediatr Child Health. 2010;46(1‒2):17–22.PubMedCrossRefGoogle Scholar
  33. 33.
    Lin JJ, Lin KL, Wang HS, et al. Effect of topiramate, in combination with lidocaine, and phenobarbital, in acute encephalitis with refractory repetitive partial seizures. Brain Dev. 2009;31(8):605–11.PubMedCrossRefGoogle Scholar
  34. 34.
    Mehta V, Singhi P, Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J Child Neurol. 2007;22(10):1191–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Yu KT, Mills S, Thompson N, et al. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Epilepsia. 2003;44(5):724–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Uberall MA, Trollmann R, Wunsiedler U, et al. Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology. 2000;54(11):2188–9.PubMedCrossRefGoogle Scholar
  37. 37.
    McTague A, Kneen R, Kumar R, et al. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital. Seizure. 2012;21(7):529–34.PubMedCrossRefGoogle Scholar
  38. 38.
    Reiter PD, Huff AD, Knupp KG, et al. Intravenous levetiracetam in the management of acute seizures in children. Pediatr Neurol. 2010;43(2):117–21.PubMedCrossRefGoogle Scholar
  39. 39.
    Kirmani BF, Crisp ED, Kayani S, et al. Role of intravenous levetiracetam in acute seizure management of children. Pediatr Neurol. 2009;41(1):37–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Akyildiz BN, Kumandas S. Treatment of pediatric refractory status epilepticus with topiramate. Childs Nerv Syst. 2011;27(9):1425–30.PubMedCrossRefGoogle Scholar
  41. 41.
    Gilbert DL, Gartside PS, Glauser TA. Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: a meta-analysis. J Child Neurol. 1999;14(9):602–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Singhi S, Murthy A, Singhi P, et al. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol. 2002;17(2):106–10.PubMedCrossRefGoogle Scholar
  43. 43.
    Holtkamp M, Masuhr F, Harms L, et al. The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists. J Neurol Neurosurg Psychiatry. 2003;74(8):1095–9.PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    Claassen J, Hirsch LJ, Mayer SA. Treatment of status epilepticus: a survey of neurologists. J Neurol Sci. 2003;211(1‒2):37–41.PubMedCrossRefGoogle Scholar
  45. 45.
    Kim SJ, Lee DY, Kim JS. Neurologic outcomes of pediatric epileptic patients with pentobarbital coma. Pediatr Neurol. 2001;25(3):217–20.PubMedCrossRefGoogle Scholar
  46. 46.
    Barberio M, Reiter PD, Kaufman J, et al. Continuous infusion pentobarbital for refractory status epilepticus in children. J Child Neurol. 2012;27(6):721–6.PubMedCrossRefGoogle Scholar
  47. 47.
    Rosati A, L'Erario M, Ilvento L, et al. Efficacy and safety of ketamine in refractory status epilepticus in children. Neurology. 2012;79(24):2355–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Ben Yehuda Y, Watemberg N. Ketamine increases opening cerebrospinal pressure in children undergoing lumbar puncture. J Child Neurol. 2006;21(6):441–3.PubMedGoogle Scholar
  49. 49.
    Himmelseher S, Durieux ME. Revising a dogma: ketamine for patients with neurological injury? Anesth Analg. 2005;101(2):524–34.PubMedCrossRefGoogle Scholar
  50. 50.
    van Gestel JP, Blusse van Oud-Alblas HJ, Malingre M, et al. Propofol and thiopental for refractory status epilepticus in children. Neurology. 2005;65(4):591–2.PubMedCrossRefGoogle Scholar
  51. 51.
    Niermeijer JM, Uiterwaal CS, Van Donselaar CA. Propofol in status epilepticus: little evidence, many dangers? J Neurol. 2003;250(10):1237–40.PubMedCrossRefGoogle Scholar
  52. 52.
    Kofke WA, Young RS, Davis P, et al. Isoflurane for refractory status epilepticus: a clinical series. Anesthesiology. 1989;71(5):653–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol. 2004;61(8):1254–9.PubMedGoogle Scholar
  54. 54.
    Guilhoto LM, Loddenkemper T, Gooty VD, et al. Experience with lacosamide in a series of children with drug-resistant focal epilepsy. Pediatr Neurol. 2011;44(6):414–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Hofler J, Trinka E. Lacosamide as a new treatment option in status epilepticus. Epilepsia. 2013;54(3):393–404.PubMedCrossRefGoogle Scholar
  56. 56.
    Shiloh-Malawsky Y, Fan Z, Greenwood R, et al. Successful treatment of childhood prolonged refractory status epilepticus with lacosamide. Seizure. 2011;20(7):586–8.PubMedCrossRefGoogle Scholar
  57. 57.
    Yoshii A, Takeoka M, Kelly PJ, et al. Focal status epilepticus as atypical presentation of pyridoxine-dependent epilepsy. J Child Neurol. 2005;20(8):696–8.PubMedCrossRefGoogle Scholar
  58. 58.
    Goutieres F, Aicardi J. Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants. Ann Neurol. 1985;17(2):117–20.PubMedCrossRefGoogle Scholar
  59. 59.
    Chou ML, Wang HS, Hung PC, et al. Late-onset pyridoxine-dependent seizures: report of two cases. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1995;36(6):434–7.PubMedGoogle Scholar
  60. 60.
    Kluger G, Blank R, Paul K, et al. Pyridoxine-dependent epilepsy: normal outcome in a patient with late diagnosis after prolonged status epilepticus causing cortical blindness. Neuropediatrics. 2008;39(5):276–9.PubMedCrossRefGoogle Scholar
  61. 61.
    Russell KE, Mulligan SR, Mallory LA. Diagnosis of pyridoxine-dependent seizures in a nineteen-year-old patient. Pediatr Neurol. 2012;47(2):141–3.PubMedCrossRefGoogle Scholar
  62. 62.
    Wang HS, Kuo MF, Chou ML, et al. Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy. Arch Dis Child. 2005;90(5):512–5.PubMedCentralPubMedCrossRefGoogle Scholar
  63. 63.
    Gospe Jr SM. Pyridoxine-dependent seizures: new genetic and biochemical clues to help with diagnosis and treatment. Curr Opin Neurol. 2006;19(2):148–53.PubMedCrossRefGoogle Scholar
  64. 64.
    Yeghiazaryan NS, Zara F, Capovilla G, et al. Pyridoxine-dependent epilepsy: an under-recognised cause of intractable seizures. J Paediatr Child Health. 2012;48(3):E113–5.PubMedCrossRefGoogle Scholar
  65. 65.
    Strzelczyk A, Reif PS, Bauer S, et al. Intravenous initiation and maintenance of ketogenic diet: Proof of concept in super-refractory status epilepticus. Seizure. 2013;22(7):581–3.PubMedCrossRefGoogle Scholar
  66. 66.
    Cervenka MC, Kossoff EH. Dietary treatment of intractable epilepsy. Continuum (Minneap Minn). 2013;19(3 Epilepsy):756–66.Google Scholar
  67. 67.
    Nordli DR, De Vivo DC. The Ketogenic Diet. In: Wyllie E, editor. Wyllie's treatment of Epilepsy. Philadelphia: Lippincott, Williams and Wilkins; 2011. p. p. 79–6.Google Scholar
  68. 68.
    Kossoff EH, Nabbout R. Use of dietary therapy for status epilepticus. J Child Neurol. 2013;28(8):1049–51.PubMedCrossRefGoogle Scholar
  69. 69.
    Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia. 2010;51(10):2033–7.PubMedCrossRefGoogle Scholar
  70. 70.
    Bhatia S, Ahmad F, Miller I, et al. Surgical treatment of refractory status epilepticus in children. J Neurosurg Pediatr. 2013;12(4):360–6.PubMedCrossRefGoogle Scholar
  71. 71.
    Guilliams K, Rosen M, Buttram S, et al. Hypothermia for pediatric refractory status epilepticus. Epilepsia. 2013;54:1586–94.PubMedCentralPubMedCrossRefGoogle Scholar
  72. 72.
    Lin JJ, Lin KL, Hsia SH, et al. Therapeutic hypothermia for febrile infection-related epilepsy syndrome in two patients. Pediatr Neurol. 2012;47(6):448–50.PubMedCrossRefGoogle Scholar
  73. 73.
    Weiner RD, Coffet CE, Fochtmann L. The practice of ECT: recommendations for treatment, training and privileging. 2nd ed. Washington DC: American Psychiatric Press; 2001.Google Scholar
  74. 74.
    Lambrecq V, Villega F, Marchal C, et al. Refractory status epilepticus: electroconvulsive therapy as a possible therapeutic strategy. Seizure. 2012;21(9):661–4.PubMedCrossRefGoogle Scholar
  75. 75.
    Cristancho MA, Alici Y, Augoustides JG, et al. Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician. Curr Psychiatry Rep. 2008;10(6):474–80.PubMedCrossRefGoogle Scholar
  76. 76.
    Srzich A, Turbott J. Nonconvulsive generalised status epilepticus following electroconvulsive therapy. Aust N Z J Psychiatry. 2000;34(2):334–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Departments of Neurology and PediatricsThe Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of PennsylvaniaPhiladelphiaUSA
  2. 2.Division of Epilepsy and Clinical Neurophysiology, Department of NeurologyBoston Children’s Hospital and Harvard Medical SchoolBostonUSA

Personalised recommendations